|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 403/06 | |
| A61K 31/505 | |||
| A61P 25/00 |
| (11) | Patento numeris | 3279195 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17179369.8 |
| Europos patento paraiškos padavimo data | 2009-11-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-02-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 118796 P | 2008-12-01 | US |
| (72) |
Akireddy, Srinivisa Rao, US
Bhatti, Balwinder Singh, US
Cuthbertson, Timothy J., US
Dull, Gary Maurice, US
Miller, Craig, Harrison, US
Mitchener, JR., Joseph Pike, US
Munoz, Julio A., US
Otten, Pieter Albert, US
|
| (73) |
Oyster Point Pharma, Inc.,
202 Carnegie Center, Suite 109, Princeton, New Jersey 08540,
US
|
| (54) | SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE |
| SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE |